STAAR Surgical Company
STAA · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 284.39M | 223.38M | 43.80M | 39.67M | 0.83 |
| 2023 FY | 322.42M | 252.65M | 28.10M | 21.35M | 0.44 |
| 2024 FY | 313.90M | 239.58M | -12.61M | -20.21M | -0.41 |
| 2025 FY | 239.44M | 182.42M | -45.95M | -80.45M | -1.62 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 418.82M | 82.71M | 86.48M | 31.04M | 336.11M |
| 2023 FY | 488.69M | 102.74M | 183.04M | 35.83M | 385.95M |
| 2024 FY | 509.52M | 112.19M | 144.16M | 38.74M | 397.34M |
| 2025 FY | 461.62M | 117.44M | 153.15M | 38.35M | 344.18M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 35.72M | -18.11M | 17.61M | — | -113.23M |
| 2023 FY | 14.59M | -18.19M | -3.59M | — | 96.56M |
| 2024 FY | 15.73M | -23.39M | -7.67M | — | -38.88M |
| 2025 FY | -34.23M | -5.82M | -40.05M | — | 8.99M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 2.33B | 2.27B | — | — | — |
| 2023 FY | 1.51B | 1.37B | — | — | — |
| 2024 FY | 1.19B | 1.08B | — | — | — |
| 2025 FY | 1.17B | 1.06B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 44.32M | 32.80M | -29.96M | -16.81M | -0.34 |
| 2025 Q3 | 94.73M | 77.88M | 18.49M | 8.88M | 0.18 |
| 2025 Q4 | 57.80M | 43.74M | -10.94M | -18.31M | -0.36 |
| 2026 Q1 | 93.52M | 67.52M | 17.40M | 5.21M | 0.10 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 437.78M | 101.21M | 167.13M | 40.52M | 336.57M |
| 2025 Q3 | 456.36M | 102.58M | 176.16M | 39.12M | 353.78M |
| 2025 Q4 | 461.62M | 117.44M | 153.15M | 38.35M | 344.18M |
| 2026 Q1 | 451.12M | 98.75M | 131.86M | 37.29M | 352.37M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | -27.25M | -1.79M | -29.04M | — | -5.98M |
| 2025 Q3 | 2.67M | -883.00K | 1.78M | — | 9.02M |
| 2025 Q4 | -3.91M | -1.68M | -5.59M | — | -23.01M |
| 2026 Q1 | -21.70M | -443.00K | -22.14M | — | -21.29M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 837.88M | 711.27M | — | — | — |
| 2025 Q3 | 1.33B | 1.19B | — | — | — |
| 2025 Q4 | 1.17B | 1.06B | — | — | — |
| 2026 Q1 | 1.01B | 914.07M | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |